These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18661535)

  • 1. Factors influencing the gastric residence of dosage forms in dogs.
    Martinez MN; Papich MG
    J Pharm Sci; 2009 Mar; 98(3):844-60. PubMed ID: 18661535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine gastrointestinal physiology: Breeds variations that can influence drug absorption.
    Oswald H; Sharkey M; Pade D; Martinez MN
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):192-203. PubMed ID: 26409436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food and species on gastric emptying rates.
    Kaniwa N; Aoyagi N; Ogata H; Ejima A
    J Pharmacobiodyn; 1988 Aug; 11(8):563-70. PubMed ID: 3236214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of particle size and food on gastric residence time of non-disintegrating solids in beagle dogs.
    Itoh T; Higuchi T; Gardner CR; Caldwell L
    J Pharm Pharmacol; 1986 Nov; 38(11):801-6. PubMed ID: 2879009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Companion animal physiology and dosage form performance.
    Sutton SC
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1383-98. PubMed ID: 15191788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
    Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug solubility classification in the dog.
    Martinez MN; Papich MG
    J Vet Pharmacol Ther; 2012 Apr; 35 Suppl 1():87-91. PubMed ID: 22413795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroretentive dosage forms.
    Moës AJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs.
    Klausner EA; Lavy E; Stepensky D; Friedman M; Hoffman A
    Pharm Res; 2002 Oct; 19(10):1516-23. PubMed ID: 12425470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of the gastric transit of floating and non-floating matrix dosage forms].
    Timmermans J
    Bull Mem Acad R Med Belg; 1990; 145(8-9):365-75. PubMed ID: 2099235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the use of Göttingen minipigs to predict food effects on the oral absorption of drugs in humans.
    Christiansen ML; Müllertz A; Garmer M; Kristensen J; Jacobsen J; Abrahamsson B; Holm R
    J Pharm Sci; 2015 Jan; 104(1):135-43. PubMed ID: 25417837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroretentive drug delivery systems.
    Streubel A; Siepmann J; Bodmeier R
    Expert Opin Drug Deliv; 2006 Mar; 3(2):217-33. PubMed ID: 16506949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulating the postprandial stomach: physiological considerations for dissolution and release testing.
    Koziolek M; Garbacz G; Neumann M; Weitschies W
    Mol Pharm; 2013 May; 10(5):1610-22. PubMed ID: 23506381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a canine model to enable the preclinical assessment of pH-dependent absorption of test compounds.
    Fancher RM; Zhang H; Sleczka B; Derbin G; Rockar R; Marathe P
    J Pharm Sci; 2011 Jul; 100(7):2979-88. PubMed ID: 21254068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sieving of solid food by the canine stomach and sieving after gastric surgery.
    Meyer JH; Thomson JB; Cohen MB; Shadchehr A; Mandiola SA
    Gastroenterology; 1979 Apr; 76(4):804-13. PubMed ID: 422008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal transit and disintegration of enteric coated magnetic tablets assessed by ac biosusceptometry.
    Corá LA; Romeiro FG; Américo MF; Oliveira RB; Baffa O; Stelzer M; Miranda JR
    Eur J Pharm Sci; 2006 Jan; 27(1):1-8. PubMed ID: 16188432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin inhibits gastric emptying and small-intestinal transit in rats and dogs.
    Ruwart MJ; Rush BD
    Gastroenterology; 1984 Aug; 87(2):392-5. PubMed ID: 6376267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.